Drug adulteration -- United States -- Prevention
Label
Drug adulteration -- United States -- Prevention
Name
Drug adulteration
Focus
Sub focus
Actions
Incoming Resources
- Subject of11
- Illicit Fentanyl from China, an evolving global operation, Lauren Greenwood, Congressional fellow, Kevin Fashola, Former Congressional fellow
- Reforming the drug compounding regulatory framework, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013
- An Act to Amend the Federal Food, Drug, and Cosmetic Act to Give Authority to the Secretary of Health and Human Services, Acting Through the Commissioner of Food and Drugs, to Destroy Counterfeit Devices
- Securing the pharmaceutical supply chain, hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, first session, on examining securing the pharmaceutical supply chain, focusing on how the Food and Drug Administration faces challenges overseeing the foreign drug manufacturing supply chain, September 14, 2011
- Tackling fentanyl, the China connection : hearing before the Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations of the Committee on Foreign Affairs, House of Representatives, One Hundred Fifteenth Congress, second session, September 6, 2018
- Counterfeit drugs, fighting illegal supply chains : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, February 27, 2014
- Pharmacy compounding: implications of the 2012 meningitis outbreak, hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session ... November 15, 2012
- An Act to Amend the Federal Food, Drug, and Cosmetic Act with Respect to Human Drug Compounding and Drug Supply Chain Security, and for Other Purposes
- Food and Drug Administration, better coordination could enhance efforts to address economic adulteration and protect the public health : report to congressional requesters
- Pharmaceutical supply chain security, Susan Thaul
- Examining implementation of the Compounding Quality Act, hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, second session, January 30, 2018
Outgoing Resources
- Focus1
- Sub focus2